nach oben

International Ophthalmology

Erschienen in:

29.06.2018 | Case Report

Fumaric acid: a possible new therapy for macular edema?

verfasst von: Lukas Kofler, Sabine Kathrein-Schneider, Katrin Schweinzer, Heinz Kofler

Erschienen in: International Ophthalmology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Causes of macular edema are multifactorial, but inflammation, vascular factors and mechanical traction are of major importance. Therapeutic options of macular edema depend on the underlying cause. Intravitreal administration of inhibitors of vascular endothelial growth factor leads to inhibition of retinal neovascularization and subsequent edema.

Objective

Fumaric acid esters are successfully used in dermatology for years according to their antiangiogenic and anti-inflammatory effects.

Result

For the very first time, we describe a successful therapeutic attempt for macular edema, controlled by optical coherence tomography using fumaric acid esters followed up for 60 months.

Dong N, Xu B, Wang B, Chu L, Tang X (2015) Aqueous cytokines as predictors of macular edema in patients with diabetes following uncomplicated phacoemulsification cataract surgery. Biomed Res Int 2015:126984–126988PubMedPubMedCentral

Funatsu H et al (2005) Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol 243:3–8CrossRefPubMed

Funatsu H et al (2003) Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 110:1690–1696CrossRefPubMed

Coleman HR, Chan C-C, Ferris FL, Chew EY (2008) Age-related macular degeneration. Lancet 372:1835–1845CrossRefPubMedPubMedCentral

Friedman DS et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564–572CrossRefPubMed

Song W-T, Xia X-B (2015) Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment. BMC Ophthalmol 15:31CrossRefPubMedPubMedCentral

Kim YT, Kang SW, Kim SJ, Kim SM, Chung SE (2012) Combination of vitrectomy, IVTA, and laser photocoagulation for diabetic macular edema unresponsive to prior treatments; 3-year results. Graefes Arch Clin Exp Ophthalmol 250:679–684CrossRefPubMed

Schweckendiek W (1959) Treatment of psoriasis vulgaris. Med Monatsschr 13:103–104PubMed

Gold R, Linker RA, Stangel M (2012) Fumaric acid and its esters: an emerging treatment for multiple sclerosis with antioxidative mechanism of action. Clin Immunol 142:44–48CrossRefPubMed

10.

Zecca C, Caporro M, Adami M, Mainetti C, Gobbi C (2014) Fumaric acid esters in psoriasis and multiple sclerosis. Clin Exp Dermatol 39:488–491CrossRefPubMed

11.

Gerdes S, Shakery K, Mrowietz U (2007) Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein beta in activated human T cells. Br J Dermatol 156:838–842CrossRefPubMed

12.

Treumer F, Zhu K, Gläser R, Mrowietz U (2003) Dimethylfumarate is a potent inducer of apoptosis in human T cells. J Invest Dermatol 121:1383–1388CrossRefPubMed

13.

Loewe R et al (2002) Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B/p65 in human endothelial cells. J Immunol 168:4781–4787CrossRefPubMed

14.

Meissner M et al (2011) Suppression of VEGFR2 expression in human endothelial cells by dimethylfumarate treatment: evidence for anti-angiogenic action. J Invest Dermatol 131:1356–1364CrossRefPubMed

15.

Arbiser JL (2011) Fumarate esters as angiogenesis inhibitors: key to action in psoriasis? J Invest Dermatol 131:1189–1191CrossRefPubMed

16.

Salgo R et al (2011) Microdialysis documents changes in the micromilieu of psoriatic plaques under continuous systemic therapy. Exp Dermatol 20:130–133CrossRefPubMed

17.

Kouris A et al (2014) Proinflammatory cytokine responses in patients with psoriasis. Eur Cytokine Netw 25:63–68PubMed

18.

Ockenfels HM, Schultewolter T, Ockenfels G, Funk R, Goos M (1998) The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 139:390–395CrossRefPubMed

Titel: Fumaric acid: a possible new therapy for macular edema?
verfasst von: Lukas Kofler
Sabine Kathrein-Schneider
Katrin Schweinzer
Heinz Kofler
Publikationsdatum: 29.06.2018
Verlag: Springer Netherlands
Erschienen in: International Ophthalmology / Ausgabe 7/2019
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-018-0982-3

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Fumaric acid: a possible new therapy for macular edema?

Abstract

Introduction

Objective

Result

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Abstract

Introduction

Objective

Result

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2019

Optimising drug therapy for non-infectious uveitis

Retinal ganglion cell complex and peripapillary retinal nerve fiber layer thicknesses following carotid endarterectomy

Agreement and repeatability of central corneal thickness measurements by four different optical devices and an ultrasound pachymeter

Pigment dispersion syndrome and pigmentary glaucoma: a review and update

YKL-40 expression in pterygium: a potential role in the pathogenesis

A new perspective for analyzing clinical characteristics of idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde